Skip to content

Branchlab

Pharma ad targeting built without patient health data

Raised to date

$28.8M

of $28.8M offered across 1 Form D filing

Investors
27
Last filed
May 20, 2026

About

BranchLab is a New York data science company that builds AI-driven advertising and audience activation software for healthcare and pharmaceutical marketing. Its platform, Pathwai, models patient, caregiver and healthcare-provider audiences using non-health demographic and behavioral signals rather than protected health information, so campaigns can be targeted without touching PHI. Advertisers can build and refine audiences, activate them across omnichannel media, and measure real-world outcomes such as prescriptions, diagnoses and healthcare visits. The company was founded in 2024 by Josh Walsh, Michael Parkes and Chris Cagle, and reports use by leading pharmaceutical brands.

An ID-less, PHI-free approach that reaches predictive targeting performance from non-health data, which BranchLab reports as roughly 3x the performance of claims-based methods at far lower cost while sidestepping the privacy constraints that slow healthcare advertising.

Funding

  • EquityFiled May 20, 2026Form D
    $28.8M/ $28.8M

Product

Pathwai

Healthcare adtech / audience activation platform

A unified AI platform for healthcare commercialization that designs, activates and measures advertising audiences optimized to real-world health outcomes, built entirely on non-PHI data.

  • Audience exploration across patient, HCP and caregiver segments without PHI
  • AI-driven audience development and refinement
  • Omnichannel activation across media channels and platforms

Built for

Pharmaceutical manufacturers and the healthcare advertising agencies, publishers and media platforms that serve them

People on file